U.S. markets open in 19 minutes
  • S&P Futures

    4,351.75
    -27.00 (-0.62%)
     
  • Dow Futures

    34,079.00
    -194.00 (-0.57%)
     
  • Nasdaq Futures

    14,842.00
    -93.25 (-0.62%)
     
  • Russell 2000 Futures

    1,789.30
    -11.60 (-0.64%)
     
  • Crude Oil

    89.15
    -0.53 (-0.59%)
     
  • Gold

    1,927.20
    -9.40 (-0.49%)
     
  • Silver

    23.27
    -0.11 (-0.49%)
     
  • EUR/USD

    1.0602
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    4.4990
    -0.0430 (-0.95%)
     
  • Vix

    17.58
    +0.68 (+4.02%)
     
  • GBP/USD

    1.2183
    -0.0029 (-0.24%)
     
  • USD/JPY

    148.8830
    +0.0480 (+0.03%)
     
  • Bitcoin USD

    26,197.30
    +93.04 (+0.36%)
     
  • CMC Crypto 200

    560.73
    +1.22 (+0.22%)
     
  • FTSE 100

    7,638.23
    +14.24 (+0.19%)
     
  • Nikkei 225

    32,315.05
    -363.57 (-1.11%)
     

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS). As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.